Stay updated on Clinical Trial: Risdiplam-Midazolam Interaction in Healthy Participants
Sign up to get notified when there's something new on the Clinical Trial: Risdiplam-Midazolam Interaction in Healthy Participants page.

Latest updates to the Clinical Trial: Risdiplam-Midazolam Interaction in Healthy Participants page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record displays details of the completed Phase I risdiplam–midazolam interaction study, including its design, outcome measures, eligibility criteria, results reporting dates, and study documents.SummaryDifference51%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now returns a 403 Forbidden error instead of the study record content, indicating access is blocked; the visible content is replaced by an error page with the site header and footer.SummaryDifference19%

Stay in the know with updates to Clinical Trial: Risdiplam-Midazolam Interaction in Healthy Participants
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Risdiplam-Midazolam Interaction in Healthy Participants page.